ArticleJournal of clinical medicine2021

Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox.

Tadeusz Robak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.